Lasa Supergenerics P/B Ratio
Lasa Supergenerics (LASA) P/B ratio is 0.74 (Low), book value per share ₹16.80 vs Healthcare average P/B of -0.29 — Low - Trading below book value, may indicate undervaluation. For live price, earnings yield and the full fundamental profile, see Lasa Supergenerics stock price NSE.
Current Valuation Metrics
Book Value Breakdown (2025)
Valuation Signal
Sector Context
LASA P/B Ratio — Valuation Insights & Book Value Analysis
Lasa Supergenerics price-to-book ratio interpretation, valuation status and historical context — current P/B 0.74 (Low). View LASA yearly price range for the annual high/low range and current price position.
- Stock appears undervalued with PB of 0.74, trading below book value
- Trading below book value - potential value opportunity or financial distress signal
- Current PB is 38.3% below historical average
- Trading at premium to sector average PB of -0.29
Lasa Supergenerics P/B Ratio Historical Trend
LASA annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Review LASA price earnings ratio to evaluate earnings-based valuation against sector peers.
LASA Historical P/B Ratio — Book Value Per Share & Year-End Price
Lasa Supergenerics annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 0.56 | ₹16.8 | ₹9.44 | ₹84 | Low |
| 2024 | 1.33 | ₹19.4 | ₹25.84 | ₹97 | Moderate |
| 2023 | 1.27 | ₹23.6 | ₹29.96 | ₹118 | Moderate |
| 2022 | 1.06 | ₹31.6 | ₹33.60 | ₹158 | Moderate |
| 2021 | 1.78 | ₹38.78 | ₹68.85 | ₹159 | Moderate |
LASA vs Healthcare Peers — P/B Ratio Comparison
Lasa Supergenerics P/B 0.74 vs Healthcare average -0.29, median 0.57 — range -14.47–1.14.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -14.47 | ₹18 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Parmax Pharma | PARMAX | -5.09 | ₹36 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.22 | ₹72 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.71 | ₹115 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.5 | ₹44 | Low |